Vanguard FTSE Developed Europe UCITS ETF | VEURRegistrer dig for at låse op for ratings |
Fondens performance | 30-11-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | -3,1 | 25,4 | -10,1 | 16,4 | 10,5 | |
+/-Kat | -1,4 | 2,6 | 3,2 | 1,9 | 3,6 | |
+/-Indeks | 0,2 | 0,1 | -0,4 | 0,2 | 0,9 | |
Kategori: Aktier - Europa Large Cap Blend | ||||||
Kategoribenchmark: Morningstar DM Eur TME NR EUR |
Oversigt | ||
Closing Price 02-12-2024 | EUR 39,93 | |
Kursændring 1 dag | 0,67% | |
Morningstar Kategori™ | Aktier - Europa Large Cap Blend | |
Omsætning | 30162 | |
Børs | EURONEXT AMSTERDAM | |
ISIN | IE00B945VV12 | |
Markedsværdi i alt (mio.) 02-12-2024 | EUR 3983,79 | |
Seneste TNA(mio.) 02-12-2024 | EUR 3061,40 | |
Løbende omkostning 26-11-2024 | 0,10% | |
Investeringsstrategi | Passiv |
Morningstar Research |
Investeringsmålsætning: Vanguard FTSE Developed Europe UCITS ETF | VEUR |
This Fund seeks to track the performance of the Index, a widely recognised benchmark a of stock market performance of European developed countries that is comprised of the stocks of large and mid cap sized companies in developed Europe. |
Returns | ||||||||||||||||
|
Management | ||
Manager navn Startdato | ||
Ikke oplyst af foreningen 21-05-2013 | ||
Startdato 21-05-2013 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
FTSE Developed Europe TR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Formuefordeling Vanguard FTSE Developed Europe UCITS ETF | VEUR | 31-10-2024 |
|
|
Top 5 placeringer | Sektor | % |
Novo Nordisk AS Class B | Healthcare | 3,08 |
ASML Holding NV | Teknologi | 2,38 |
SAP SE | Teknologi | 2,29 |
Nestle SA | Forbrugsvarer | 2,17 |
Novartis AG Registered Shares | Healthcare | 1,98 |
Øget Mindsket Ny siden sidste portefølje | ||
Vanguard FTSE Developed Europe UCITS ETF | VEUR |